Keyphrases
Adult Patients
14%
Amitriptyline
14%
Area under the Receiver Operating Characteristic Curve
14%
Atenolol
14%
Attack Response
14%
Beta-blockers
42%
Binary Outcome
14%
Body Mass Index
14%
Calcitonin Gene-related Peptide
14%
Calcitonin Gene-related Peptide Monoclonal Antibody
57%
Clinical Features
14%
Comorbid Factors
14%
Confidence Interval
100%
Cranial Autonomic Symptoms
14%
Deep Neural Network
14%
Embedded Data
14%
Eptinezumab
14%
Erenumab
14%
Family History
14%
Fremanezumab
14%
Gabapentin
42%
Galcanezumab
14%
Headache
42%
Headache Attacks
14%
High Body Mass Index
14%
History of Headache
14%
Imaging Factors
14%
Low Body Mass Index
14%
Machine Learning Models
100%
Mayo Clinic
14%
Medical Comorbidity
14%
Medical Genomics
14%
Medical Imaging
14%
Medication Changes
14%
Metoprolol
14%
Migraine
100%
Migraine Attack
28%
Migraine Prevention
42%
Migraine Treatment
100%
Model Performance
42%
Monthly Migraine Days
42%
Nadolol
14%
Non-responders
14%
Nortriptyline
14%
OnabotulinumtoxinA
42%
Predicting Treatment Response
14%
Prediction Accuracy
14%
Prediction Model
57%
Preventative Medicine
100%
Propranolol
14%
Responder Rate
14%
Response Predictors
100%
Shapley Additive Explanations
14%
Starting Treatment
14%
TabNet
28%
Therapeutic Monoclonal Antibody
14%
Time-to-treatment
14%
Timolol
14%
Topiramate
42%
Treatment Outcome
14%
Treatment Responder
14%
Treatment Response
28%
Trial-and-error
14%
Tricyclic Antidepressants
28%
Verapamil
28%
Neuroscience
Aluminum Glycinate
15%
Amitriptyline
7%
Atenolol
7%
Beta Blocker
23%
Body Mass Index
23%
Botulinum Toxin A
23%
Calcitonin Gene Related Peptide
38%
Calcitonin Gene-Related Peptide
38%
Comorbidity
7%
Eptinezumab
7%
Erenumab
7%
Fremanezumab
7%
Gabapentin
23%
Galcanezumab
7%
Headache
53%
Metoprolol
7%
Migraine
100%
Monoclonal Antibody
30%
Nadolol
7%
Neural Network
7%
Nortriptyline
7%
Prediction Model
30%
Propranolol
7%
Timolol
7%
Topiramate
23%
Tricyclic Antidepressant
15%
Verapamil
15%
Pharmacology, Toxicology and Pharmaceutical Science
Aluminum Glycinate
15%
Amitriptyline
7%
Atenolol
7%
Beta Adrenergic Receptor Blocking Agent
23%
Botulinum Toxin A
23%
Calcitonin Gene Related Peptide
38%
Clinical Feature
7%
Cohort Study
7%
Comorbidity
7%
Diseases
7%
Eptinezumab
7%
Erenumab
7%
Fremanezumab
7%
Gabapentin
23%
Galcanezumab
7%
Headache
53%
Metoprolol
7%
Migraine
100%
Monoclonal Antibody
30%
Nadolol
7%
Nortriptyline
7%
Propranolol
7%
Timolol
7%
Topiramate
23%
Tricyclic Antidepressant
15%
Verapamil
15%